Stock Research for ADMA


Featured Broker: Ally Invest

Get the due diligence for another stock.


ADMA Stock Chart & Research Data

The ADMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ADMA Due diligence Resources & Stock Charts

The ADMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ADMA Detailed Price Forecast - CNN Money CNN View ADMA Detailed Summary - Google Finance
Yahoo View ADMA Detailed Summary - Yahoo! Finance Zacks View ADMA Stock Research & Analysis -

Stock Analysis

TradeIdeas View ADMA Trends & Analysis - Trade-Ideas Barrons View ADMA Major Holders - Barrons
NASDAQ View ADMA Call Transcripts - NASDAQ Seeking View ADMA Breaking News & Analysis - Seeking Alpha
Spotlight View ADMA Annual Report - OTC Report View ADMA OTC Short Report -
TradeKing View ADMA Fundamentals - TradeKing Charts View ADMA SEC Filings - Bar Chart
WSJ View Historical Prices for ADMA - The WSJ Morningstar View Performance/Total Return for ADMA - Morningstar
MarketWatch View the Analyst Estimates for ADMA - MarketWatch CNBC View the Earnings History for ADMA - CNBC
StockMarketWatch View the ADMA Earnings - StockMarketWatch MacroAxis View ADMA Buy or Sell Recommendations - MacroAxis
Bullish View the ADMA Bullish Patterns - American Bulls Short Pains View ADMA Short Pain Metrics -

Social Media Mentions

StockTwits View ADMA Stock Mentions - StockTwits PennyStocks View ADMA Stock Mentions - PennyStockTweets
Twitter View ADMA Stock Mentions - Twitter Invest Hub View ADMA Investment Forum News - Investor Hub
Yahoo View ADMA Stock Mentions - Yahoo! Message Board Seeking Alpha View ADMA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ADMA - Insider Cow View Insider Transactions for ADMA - Insider Cow
CNBC View ADMA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ADMA - OTC Markets
Yahoo View Insider Transactions for ADMA - Yahoo! Finance NASDAQ View Institutional Holdings for ADMA - NASDAQ

Stock Charts

FinViz View ADMA Stock Insight & Charts - StockCharts View ADMA Investment Charts -
BarChart View ADMA Stock Overview & Charts - BarChart Trading View View ADMA User Generated Charts - Trading View

Latest Financial News for ADMA

ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved
Posted on Wednesday September 05, 2018

ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the prevention and treatment of certain infectious diseases, announces that the United States Food and Drug Administration (“FDA”) inspection database classification website has been updated and confirms ADMA’s compliance status has improved to Voluntary Action Indicated (“VAI”). “We are pleased that the FDA has acknowledged the improved current good manufacturing practice (“cGMP”) conditions at our manufacturing facility and updated its database accordingly,” stated Adam Grossman, President and Chief Executive Officer of ADMA Biologics, Inc. “We are excited to finally be in a position to resubmit our Biologics License Application (“BLA”) for RI-002 during the third quarter of 2018, which we believe is a needed Intravenous Immune Globulin (“IVIG”) option for patients who suffer with Primary Humoral Immunodeficiency Disease (“PIDD”).

Penny Stocks to Watch for September 2018
Posted on Friday August 31, 2018

Junior miners turned lower in sympathy with declining gold and silver contracts, while small biotech and medical diagnostic stocks picked up the slack, underpinned by sector funds probing new highs. September has a mixed reputation when it comes to small speculative plays, suggesting that traders focus their attention on penny stocks exhibiting the highest relative strength while avoiding falling knives that may face tax selling pressure in the fourth quarter. Low-priced energy stocks look like wild cards in this equation, with crude oil coming off lows while rising Middle East tensions add to sector buying power.

ADMA: FDA Submissions are Next Milestones
Posted on Monday August 27, 2018

ADMA Biologics, Inc. (ADMA) filed its 10-K and press release for its second quarter 2018 financial results on August 10, 2018. The highlights year to date have included the release of the first commercial batch of Nabi-HB to be manufactured under ADMA ownership, the retirement of 8.6 million shares issued to Biotest and the grant of a patent for treating respiratory infections related to RI-002. On June 12, ADMA closed $40 million in equity financing followed just over six weeks later by the successful close out of the FDA compliance inspection.

ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
Posted on Monday August 27, 2018

RAMSEY, N.J. and BOCA RATON, Fla., Aug. 27, 2018-- ADMA Biologics, Inc., a vertically integrated commercial biopharmaceutical company that develops, manufactures and markets specialty plasma-based biologics ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.